TrialClinical pharmacology in drug development2022

Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects.

Anjaneya Chimalakonda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.